News
June 08, 2023
Public Expose: Phapros' (PEHA) 2023 Strategy Focuses on Innovative Business Development, Digitalization, and Human Resources Development
Phapros held its Annual General Meeting of Shareholders for the 2022 fiscal year, followed by a public expose by the company...
See More
May 31, 2023
Phapros Expands Product Development Through Collaboration and Innovation
Phapros is currently undertaking product development initiatives through strategic collaborations with various parties, including its subsidiary PT Lucas Djaja, as well as domestic n global....
See More
May 23, 2023
Digitalization of Technology Becomes the Solution for the Pharmaceutical Industry
Digital transformation has become a necessity in today's industrial world, especially in the pharmaceutical sector....
See More
April 28, 2023
Phapros recorded 8.9% growth for its ethical products in the first quarter of 2023.
Phapros CEO, Hadi Kardoko, stated that the growth of Phapros' branded prescription drugs (ethical products) in the first quarter of 2023 increased by 8.9% compared to the previous year....
See More
April 11, 2023
Welcoming the 2023 Eid al-Fitr Homecoming, Phapros Prepares Tens of Thousands of Product Packages and Antimo Posts
PT Phapros Tbk is preparing various programs to enliven the 2023 Eid al-Fitr homecoming moment with its legendary product, Antimo....
See More
March 29, 2023
Current Year's Profit of PEHA Increases Significantly by 143 Percent, Analysts Evaluate Its Stock as Prospective.
PEHA recorded a sales growth of 11 percent and a significant current year's profit increase of 143 percent....
See More